Kwame Ulmer is the Managing Partner at MedTech Impact Partners, bringing over two decades of experience evaluating medical technologies in both the government and private sectors. He is also a Venture Partner at Wavemaker Three-Sixty Health, where he leads the MedTech practice and is actively involved in all aspects of fund management, including deal sourcing, diligence, negotiation, and advising portfolio company management teams.

Aiden Aceves is a Vice President on the investments team at Insight. He joined the firm in 2021 to focus on investments in therapeutics and enabling technologies. Aiden was previously an associate at Vida Ventures, where he worked in the firm's LA office making investments in innovative cell and gene therapy companies. Prior to becoming an investor, Aiden worked on founding and operating biotechnology companies in San Diego California, where he is based. Aiden traces his academic lineage to Caltech, where he earned his doctorate in the lab of Dr. Steven Mayo, a leader in the space of computational protein engineering. Aiden received his B.S. in synthetic chemistry from the University of California, Riverside.

Bobby Edelman is an active angel investor and advisor who has worked with over hundreds of early-stage companies—more than 80 of them paid clients in the past 16 months—across sectors including genomics, medtech, and health and wellness. He’s invested in 140+ startups directly, via equity crowdfunding platforms, and through funds like NuFund, Interlock Capital, and the San Diego Angel Conference. A former tech exec who helped scale a $200M business and contributed to the $800M sale of Marshall Electronics, Bobby specializes in helping founders raise capital, refine their pitch, and become investor-ready.

‍

Ralph Morales III is an accomplished leader in the wearables and health tech space, with over 15 years of experience driving innovation and market growth. He has held pivotal roles at companies like Oura, where he led the development of healthcare solutions that generated significant revenue and expanded digital health capabilities. Ralph is a solution advocate for integrating digital biomarkers and real-time health insights to improve therapeutic outcomes and advance health span.  

‍

From analyst to product development, Nicholas leads the market intelligence team at LSI. He brings over a decade of experience in market research and consulting for venture-backed medtech companies and private equity firms.

Dr. Hongbo Zhao is a venture capital investor specializing in medical technology and healthcare innovation. He is currently part of the healthcare investment team at Gaorong Ventures, a leading venture capital firm with a strong presence in China and a global investment outlook. At Gaorong, Dr. Zhao focuses on medical device investments, supporting emerging innovations and commercialization strategies in the industry.

Doc Vu is the founder of DeviceLab and a hands-on leader in connected medical technology. With 25+ years of experience, he has completed over 400 medical devices and systems—many of which have successfully gone to market. These include diagnostic devices, wearables, and patient monitors, often featuring wireless platforms that close the loop between clinic and home. He has built and led engineering teams that move fast and deliver results across complex systems—firmware, electronics, wireless, and regulatory. Doc stays close to execution, focused on solving hard problems and getting high-impact products across the finish line.

Glen has over 30 years of medical device product development, innovation and leadership experience. Glen is a renown ultrasound imaging technologist and a principal inventor of software-based zone sonography technology. Glen presently serves as CEO of YorLabs, where he is leading the development of a new standard setting solution in intracardiac image guided therapy. Prior to YorLabs, he served as President of Innovation & Development, VP Global Partnerships, and Chief Product Officer of Mindray Medical International, the largest medical device company in China. He previously served as Zonare’s Vice President of Engineering for over 12 years, having led all technology and product development. Zonare was acquired by Mindray in 2013. At Zonare, he established and managed a world class engineering team to cover all aspects of engineering development, including electrical, mechanical, software, regulatory, transducers, and imaging physics. At Mindray/Zonare, Glen has brought over a dozen products to market generating over $200M of revenue. He holds 70 issued patents with over 30 additional pending in the medical device field.